Dyne Therapeutics Inc
DYN · NASDAQ
Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States.
Market Data
Price
$19.19
+1.00 (+5.50%)
Market Cap—
P/E Ratio—
EPS$—
52W High$—
52W Low$—
Beta—
Data from Finnhub · Updated Jun 15, 2026